| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |